Abstract
Two series of (nicotinonitrile-thiazole)-based Schiff bases 1 and their bis(Schiff bases) analogs 2 are efficiently prepared in this study. A one-pot protocol was designed to prepare the target products involved the reaction of the respective nicotinonitrile-based salicylaldehyde, thiosemicarbazide, and the appropriate mono- or bis(α-haloketones). The reaction was heated at 100 °C for 5–8 h in dioxane and mediated by triethylamine to produce the target hybrids in 80–92% yields. Generally, the (nicotinonitrile-thiazole)-based Schiff bases 1 demonstrated superior antibacterial activity over their bis(Schiff bases) analogs 2. The antibacterial activity of Schiff bases 1d and 1e linked to p-tolyl and 4-methoxyphenyl units was the best against Staphylococcus aureus, Enterococcus faecalis, Escherichia coli, and Pseudomonas aeruginosa strains. They had MIC and MBC values ranging from 3.8 to 4.0 and 7.7 to 8.0 µM, respectively. Using SwissADME to predict the physicochemical properties, lipophilicity, and drug-likeness of new products, Schiff bases 1 can be considered as drug-like scaffolds.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
